FOUND: 4 - You Need To See This

MarketBeat Week in Review – 08/31 - 09/04

Stocks pulled back after a strong jobs report stoked rate-hike concerns. MarketBeat writers recap earnings-season themes, covering AI, cybersecurity, retail, energy, and dividend stocks.

MarketBeat · Sep 5

Revolution Medicines Got Its Breakthrough—What Moves It Next?

FDA approved Revolution Medicines' RASONQUE for pancreatic cancer, but RVMD stock stayed flat as investors had priced in the news early, with rising expenses now in focus.

MarketBeat · Sep 4

Credo Technology Just Plunged 20%—Did the Market Overreact?

Credo Technologies stock fell 20% despite a Q1 FY2027 revenue and EPS beat and raised guidance, as analysts cite margin compression but maintain a bullish Moderate Buy consensus.

MarketBeat · Sep 4

Wendy’s Rally Fades After Trian Steps Back: Was It Ever Real?

Wendy's stock spiked on Trian buyout reports, reversed after the firm backed off, then recovered on short covering and value buying, even as weak earnings and bearish analyst ratings persist.

MarketBeat · Sep 2

GitLab’s Earnings Beat Just Gave Software Bulls a New SaaSpocalypse Test

GitLab shares surged over 20% after Q2 FY2027 revenue rose 21.3% and guidance improved, with analysts raising price targets and institutions accumulating shares amid strong enterprise demand.

MarketBeat · Sep 2

What Does Apple's TV Price Hike Say About Where the Stock Is Heading?

Apple raised Apple TV and Apple One prices up to 20%, highlighting its services-driven strategy as new CEO John Ternus takes over and shares trade near record highs.

MarketBeat · Sep 2

Medtronic’s Stars Are Aligning for a Price Recovery

Medtronic beat Q1 FY2027 estimates, raised guidance, and holds a Moderate Buy rating from analysts, with its 3%-plus dividend positioning it near Dividend King status.

MarketBeat · Sep 1

Analysts See Major Upside for This Top-10 Performing S&P 500 Stock

Lumentum shares have surged about 140% in 2025 on AI optical demand, backed by strong earnings growth and a Moderate Buy rating with roughly 22% analyst upside.

MarketBeat · Sep 1

Salesforce Looks Overbought, But the Rally May Be Far From Over

Salesforce shares surged after strong earnings and raised guidance, with Agentforce revenue tripling and analysts reiterating Buy ratings, even as an overbought RSI signals a possible near-term pullback.

MarketBeat · Sep 1

Securing AI: 5 Most-Upgraded Stocks From the Q2 Reporting Season

Okta, CrowdStrike, Datadog, Cloudflare and Palo Alto Networks led Q2's most-upgraded stocks as AI-driven agentic traffic boosts cybersecurity demand, with analysts raising price targets and ratings.

MarketBeat · Aug 31